Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Therapeutische Umschau. Revue Therapeutique|November 3, 2011
[Immunostimulating drugs and cytokines]Nicola Lehners, Hartmut Goldschmidt, Marc S Raab
Emerging Infectious Diseases|May 24, 2013
Changes in severity of influenza A(H1N1)pdm09 infection from pandemic to first postpandemic season, GermanyNicola Lehners, Steffen Geis, Christoph Eisenbach, et al.
Expert Review of Hematology|June 24, 2016
Management of high-risk Myeloma: an evidence-based review of treatment strategiesNicola Lehners, Patrick J Hayden, Hartmut Goldschmidt, et al.
Leukemia & Lymphoma|March 22, 2016
Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab eraNicola Lehners, Isabelle Krämer, Mark-Alexander Schwarzbich, et al.
Annals of Hematology|July 3, 2017
The influence of rituximab-containing chemotherapy on HCV load in patients with HCV-associated non-Hodgkin's lymphomasXiang Zhou, Katharina Lisenko, Nicola Lehners, et al.
BMC Cancer|February 15, 2017
Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvementNicola Lehners, Isabelle Krämer, Maral Saadati, et al.
Histopathology|November 21, 2013
Expression of Mucin-1 in multiple myeloma and its precursors: correlation with glycosylation and subcellular localizationMindaugas Andrulis, Elena Ellert, Ulla Mandel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2017
Pretransplant Vitamin D Deficiency Is Associated With Higher Relapse Rates in Patients Allografted for Myeloid MalignanciesAleksandar Radujkovic, Lambros Kordelas, Julia Krzykalla, et al.
Leukemia & Lymphoma|April 5, 2018
Oncogene-induced senescence: a potential breakpoint mechanism against malignant transformation in plasma cell disordersNicola Lehners, Elena Ellert, Jing Xu, et al.
Cancer Medicine|December 29, 2017
Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation: impact of clinical risk factors and sustained responseNicola Lehners, Natalia Becker, Axel Benner, et al.
Pageof 3